| UniProt ID | SMC4_HUMAN | |
|---|---|---|
| UniProt AC | Q9NTJ3 | |
| Protein Name | Structural maintenance of chromosomes protein 4 | |
| Gene Name | SMC4 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 1288 | |
| Subcellular Localization | Nucleus . Cytoplasm . Chromosome . In interphase cells, the majority of the condensin complex is found in the cytoplasm, while a minority of the complex is associated with chromatin. A subpopulation of the complex however remains associated with chro | |
| Protein Description | Central component of the condensin complex, a complex required for conversion of interphase chromatin into mitotic-like condense chromosomes. The condensin complex probably introduces positive supercoils into relaxed DNA in the presence of type I topoisomerases and converts nicked DNA into positive knotted forms in the presence of type II topoisomerases.. | |
| Protein Sequence | MPRKGTQPSTARRREEGPPPPSPDGASSDAEPEPPSGRTESPATAAETASEELDNRSLEEILNSIPPPPPPAMTNEAGAPRLMITHIVNQNFKSYAGEKILGPFHKRFSCIIGPNGSGKSNVIDSMLFVFGYRAQKIRSKKLSVLIHNSDEHKDIQSCTVEVHFQKIIDKEGDDYEVIPNSNFYVSRTACRDNTSVYHISGKKKTFKDVGNLLRSHGIDLDHNRFLILQGEVEQIAMMKPKGQTEHDEGMLEYLEDIIGCGRLNEPIKVLCRRVEILNEHRGEKLNRVKMVEKEKDALEGEKNIAIEFLTLENEIFRKKNHVCQYYIYELQKRIAEMETQKEKIHEDTKEINEKSNILSNEMKAKNKDVKDTEKKLNKITKFIEENKEKFTQLDLEDVQVREKLKHATSKAKKLEKQLQKDKEKVEEFKSIPAKSNNIINETTTRNNALEKEKEKEEKKLKEVMDSLKQETQGLQKEKESREKELMGFSKSVNEARSKMDVAQSELDIYLSRHNTAVSQLTKAKEALIAASETLKERKAAIRDIEGKLPQTEQELKEKEKELQKLTQEETNFKSLVHDLFQKVEEAKSSLAMNRSRGKVLDAIIQEKKSGRIPGIYGRLGDLGAIDEKYDVAISSCCHALDYIVVDSIDIAQECVNFLKRQNIGVATFIGLDKMAVWAKKMTEIQTPENTPRLFDLVKVKDEKIRQAFYFALRDTLVADNLDQATRVAYQKDRRWRVVTLQGQIIEQSGTMTGGGSKVMKGRMGSSLVIEISEEEVNKMESQLQNDSKKAMQIQEQKVQLEERVVKLRHSEREMRNTLEKFTASIQRLIEQEEYLNVQVKELEANVLATAPDKKKQKLLEENVSAFKTEYDAVAEKAGKVEAEVKRLHNTIVEINNHKLKAQQDKLDKINKQLDECASAITKAQVAIKTADRNLQKAQDSVLRTEKEIKDTEKEVDDLTAELKSLEDKAAEVVKNTNAAEESLPEIQKEHRNLLQELKVIQENEHALQKDALSIKLKLEQIDGHIAEHNSKIKYWHKEISKISLHPIEDNPIEEISVLSPEDLEAIKNPDSITNQIALLEARCHEMKPNLGAIAEYKKKEELYLQRVAELDKITYERDSFRQAYEDLRKQRLNEFMAGFYIITNKLKENYQMLTLGGDAELELVDSLDPFSEGIMFSVRPPKKSWKKIFNLSGGEKTLSSLALVFALHHYKPTPLYFMDEIDAALDFKNVSIVAFYIYEQTKNAQFIIISLRNNMFEISDRLIGIYKTYNITKSVAVNPKEIASKGLC | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 4 | Methylation | ----MPRKGTQPSTA ----CCCCCCCCCCC | 76.63 | 116253841 | |
| 6 | Phosphorylation | --MPRKGTQPSTARR --CCCCCCCCCCCCC | 40.10 | 25137130 | |
| 22 | Phosphorylation | EEGPPPPSPDGASSD CCCCCCCCCCCCCCC | 41.20 | 29255136 | |
| 27 | Phosphorylation | PPSPDGASSDAEPEP CCCCCCCCCCCCCCC | 33.99 | 29255136 | |
| 28 | Phosphorylation | PSPDGASSDAEPEPP CCCCCCCCCCCCCCC | 40.06 | 29255136 | |
| 36 | Phosphorylation | DAEPEPPSGRTESPA CCCCCCCCCCCCCCC | 52.18 | 30266825 | |
| 39 | Phosphorylation | PEPPSGRTESPATAA CCCCCCCCCCCCHHH | 44.32 | 22167270 | |
| 41 | Phosphorylation | PPSGRTESPATAAET CCCCCCCCCCHHHHH | 21.15 | 19664994 | |
| 44 | Phosphorylation | GRTESPATAAETASE CCCCCCCHHHHHHCH | 29.77 | 19664994 | |
| 48 | Phosphorylation | SPATAAETASEELDN CCCHHHHHHCHHHCC | 30.66 | 23927012 | |
| 50 | Phosphorylation | ATAAETASEELDNRS CHHHHHHCHHHCCCC | 38.74 | 30266825 | |
| 57 | Phosphorylation | SEELDNRSLEEILNS CHHHCCCCHHHHHHC | 46.52 | 20873877 | |
| 85 | Phosphorylation | GAPRLMITHIVNQNF CCCCEEEEHHHCCCH | 7.50 | - | |
| 93 | Methylation | HIVNQNFKSYAGEKI HHHCCCHHHHCCCCC | 50.54 | 100328913 | |
| 93 | Ubiquitination | HIVNQNFKSYAGEKI HHHCCCHHHHCCCCC | 50.54 | - | |
| 99 | Ubiquitination | FKSYAGEKILGPFHK HHHHCCCCCCCCCCC | 42.17 | - | |
| 106 | Acetylation | KILGPFHKRFSCIIG CCCCCCCCCEEEEEC | 56.36 | 25953088 | |
| 106 | Ubiquitination | KILGPFHKRFSCIIG CCCCCCCCCEEEEEC | 56.36 | - | |
| 109 | Phosphorylation | GPFHKRFSCIIGPNG CCCCCCEEEEECCCC | 14.40 | - | |
| 119 | Methylation | IGPNGSGKSNVIDSM ECCCCCCCCCHHHHH | 40.32 | 115980899 | |
| 120 | Phosphorylation | GPNGSGKSNVIDSML CCCCCCCCCHHHHHH | 39.59 | 21406692 | |
| 125 | Phosphorylation | GKSNVIDSMLFVFGY CCCCHHHHHHHHHHH | 13.27 | 21406692 | |
| 132 | Phosphorylation | SMLFVFGYRAQKIRS HHHHHHHHHHHHHHH | 7.42 | 21406692 | |
| 141 | Ubiquitination | AQKIRSKKLSVLIHN HHHHHHCCEEEEEEC | 47.44 | - | |
| 143 | Phosphorylation | KIRSKKLSVLIHNSD HHHHCCEEEEEECCC | 24.61 | 25159151 | |
| 149 | Phosphorylation | LSVLIHNSDEHKDIQ EEEEEECCCCCCCHH | 30.16 | 25159151 | |
| 153 | Ubiquitination | IHNSDEHKDIQSCTV EECCCCCCCHHHCEE | 55.25 | - | |
| 170 | Ubiquitination | HFQKIIDKEGDDYEV EEEEHHHCCCCCCEE | 53.86 | - | |
| 175 | Phosphorylation | IDKEGDDYEVIPNSN HHCCCCCCEECCCCC | 19.48 | 25147952 | |
| 184 | Phosphorylation | VIPNSNFYVSRTACR ECCCCCEEEEEEEEC | 11.19 | 29496907 | |
| 188 | Phosphorylation | SNFYVSRTACRDNTS CCEEEEEEEECCCCE | 23.70 | - | |
| 194 | Phosphorylation | RTACRDNTSVYHISG EEEECCCCEEEEEEC | 24.69 | 28152594 | |
| 195 | Phosphorylation | TACRDNTSVYHISGK EEECCCCEEEEEECC | 27.25 | 28152594 | |
| 197 | Phosphorylation | CRDNTSVYHISGKKK ECCCCEEEEEECCCC | 8.00 | 28152594 | |
| 200 | Phosphorylation | NTSVYHISGKKKTFK CCEEEEEECCCCCHH | 31.11 | 28152594 | |
| 202 | 2-Hydroxyisobutyrylation | SVYHISGKKKTFKDV EEEEEECCCCCHHHH | 44.28 | - | |
| 202 | Acetylation | SVYHISGKKKTFKDV EEEEEECCCCCHHHH | 44.28 | 25953088 | |
| 202 | Ubiquitination | SVYHISGKKKTFKDV EEEEEECCCCCHHHH | 44.28 | 21890473 | |
| 202 (in isoform 1) | Ubiquitination | - | 44.28 | 21890473 | |
| 202 (in isoform 2) | Ubiquitination | - | 44.28 | 21890473 | |
| 203 | Ubiquitination | VYHISGKKKTFKDVG EEEEECCCCCHHHHH | 61.65 | - | |
| 204 | Ubiquitination | YHISGKKKTFKDVGN EEEECCCCCHHHHHH | 63.78 | - | |
| 207 | Acetylation | SGKKKTFKDVGNLLR ECCCCCHHHHHHHHH | 57.65 | 25953088 | |
| 207 | Ubiquitination | SGKKKTFKDVGNLLR ECCCCCHHHHHHHHH | 57.65 | 21890473 | |
| 207 (in isoform 1) | Ubiquitination | - | 57.65 | 21890473 | |
| 207 (in isoform 2) | Ubiquitination | - | 57.65 | 21890473 | |
| 214 | Methylation | KDVGNLLRSHGIDLD HHHHHHHHHCCCCCC | 29.76 | 115917257 | |
| 239 | Ubiquitination | VEQIAMMKPKGQTEH EEEEEECCCCCCCCC | 30.41 | - | |
| 241 | Ubiquitination | QIAMMKPKGQTEHDE EEEECCCCCCCCCCH | 59.12 | - | |
| 250 | Sulfoxidation | QTEHDEGMLEYLEDI CCCCCHHHHHHHHHH | 2.12 | 30846556 | |
| 268 | Acetylation | GRLNEPIKVLCRRVE CCCCHHHHHHHHHHH | 39.61 | 23749302 | |
| 268 | Ubiquitination | GRLNEPIKVLCRRVE CCCCHHHHHHHHHHH | 39.61 | - | |
| 281 | Methylation | VEILNEHRGEKLNRV HHHHHHCCCCCCCCC | 49.11 | 115917261 | |
| 284 | Acetylation | LNEHRGEKLNRVKMV HHHCCCCCCCCCEEE | 54.61 | 26051181 | |
| 289 | 2-Hydroxyisobutyrylation | GEKLNRVKMVEKEKD CCCCCCCEEEHHHHH | 33.71 | - | |
| 293 | Ubiquitination | NRVKMVEKEKDALEG CCCEEEHHHHHHHHC | 59.67 | - | |
| 319 | 2-Hydroxyisobutyrylation | ENEIFRKKNHVCQYY CHHHHHCCCCHHHHH | 48.29 | - | |
| 332 | Ubiquitination | YYIYELQKRIAEMET HHHHHHHHHHHHHHH | 59.40 | - | |
| 341 | Ubiquitination | IAEMETQKEKIHEDT HHHHHHHHHHHHHHH | 69.28 | - | |
| 343 | Ubiquitination | EMETQKEKIHEDTKE HHHHHHHHHHHHHHH | 57.30 | - | |
| 348 | Phosphorylation | KEKIHEDTKEINEKS HHHHHHHHHHHHHHH | 27.82 | 20860994 | |
| 349 | Acetylation | EKIHEDTKEINEKSN HHHHHHHHHHHHHHC | 69.76 | 23749302 | |
| 349 | Ubiquitination | EKIHEDTKEINEKSN HHHHHHHHHHHHHHC | 69.76 | - | |
| 354 | 2-Hydroxyisobutyrylation | DTKEINEKSNILSNE HHHHHHHHHCCCCHH | 44.29 | - | |
| 354 | Acetylation | DTKEINEKSNILSNE HHHHHHHHHCCCCHH | 44.29 | 19827019 | |
| 354 | Ubiquitination | DTKEINEKSNILSNE HHHHHHHHHCCCCHH | 44.29 | - | |
| 355 | Phosphorylation | TKEINEKSNILSNEM HHHHHHHHCCCCHHH | 23.95 | 19691289 | |
| 363 | Acetylation | NILSNEMKAKNKDVK CCCCHHHHHCCCCHH | 50.45 | 25953088 | |
| 363 | Ubiquitination | NILSNEMKAKNKDVK CCCCHHHHHCCCCHH | 50.45 | - | |
| 381 | Acetylation | KKLNKITKFIEENKE HHHHHHHHHHHHCHH | 48.06 | 19608861 | |
| 381 | Ubiquitination | KKLNKITKFIEENKE HHHHHHHHHHHHCHH | 48.06 | 19608861 | |
| 387 | Acetylation | TKFIEENKEKFTQLD HHHHHHCHHHHHCCC | 66.61 | 25953088 | |
| 389 | Ubiquitination | FIEENKEKFTQLDLE HHHHCHHHHHCCCHH | 56.15 | 21890473 | |
| 389 (in isoform 1) | Ubiquitination | - | 56.15 | 21890473 | |
| 389 (in isoform 2) | Ubiquitination | - | 56.15 | 21890473 | |
| 409 | Phosphorylation | EKLKHATSKAKKLEK HHHHHHHHHHHHHHH | 31.25 | 25367160 | |
| 413 | Ubiquitination | HATSKAKKLEKQLQK HHHHHHHHHHHHHHH | 67.73 | 21890473 | |
| 413 (in isoform 1) | Ubiquitination | - | 67.73 | 21890473 | |
| 413 (in isoform 2) | Ubiquitination | - | 67.73 | 21890473 | |
| 416 | Acetylation | SKAKKLEKQLQKDKE HHHHHHHHHHHHHHH | 67.74 | 23749302 | |
| 416 | Ubiquitination | SKAKKLEKQLQKDKE HHHHHHHHHHHHHHH | 67.74 | - | |
| 434 | Ubiquitination | EFKSIPAKSNNIINE HHHCCCCCCCCCCCC | 48.65 | - | |
| 444 | Phosphorylation | NIINETTTRNNALEK CCCCCCCHHCHHHHH | 38.53 | 21601212 | |
| 464 | Sulfoxidation | EKKLKEVMDSLKQET HHHHHHHHHHHHHHH | 2.80 | 21406390 | |
| 466 | Phosphorylation | KLKEVMDSLKQETQG HHHHHHHHHHHHHHH | 21.26 | 28985074 | |
| 483 | Acetylation | KEKESREKELMGFSK HHHHHHHHHHHHHHH | 55.85 | 25953088 | |
| 489 | Phosphorylation | EKELMGFSKSVNEAR HHHHHHHHHHHHHHH | 20.49 | - | |
| 490 | Acetylation | KELMGFSKSVNEARS HHHHHHHHHHHHHHH | 57.04 | 25953088 | |
| 511 | Phosphorylation | SELDIYLSRHNTAVS HHHHHHHHCCCHHHH | 17.96 | 30257219 | |
| 515 | Phosphorylation | IYLSRHNTAVSQLTK HHHHCCCHHHHHHHH | 23.47 | 21406692 | |
| 518 | Phosphorylation | SRHNTAVSQLTKAKE HCCCHHHHHHHHHHH | 19.60 | 21406692 | |
| 521 | Phosphorylation | NTAVSQLTKAKEALI CHHHHHHHHHHHHHH | 22.71 | 21406692 | |
| 522 | 2-Hydroxyisobutyrylation | TAVSQLTKAKEALIA HHHHHHHHHHHHHHH | 67.08 | - | |
| 522 | Ubiquitination | TAVSQLTKAKEALIA HHHHHHHHHHHHHHH | 67.08 | - | |
| 524 | 2-Hydroxyisobutyrylation | VSQLTKAKEALIAAS HHHHHHHHHHHHHCH | 45.11 | - | |
| 531 | Phosphorylation | KEALIAASETLKERK HHHHHHCHHHHHHHH | 23.30 | - | |
| 533 | Phosphorylation | ALIAASETLKERKAA HHHHCHHHHHHHHHH | 40.40 | - | |
| 547 | Ubiquitination | AIRDIEGKLPQTEQE HHHHHCCCCCHHHHH | 44.17 | - | |
| 551 | Phosphorylation | IEGKLPQTEQELKEK HCCCCCHHHHHHHHH | 37.38 | 25003641 | |
| 564 | Acetylation | EKEKELQKLTQEETN HHHHHHHHHHHHHHH | 67.15 | 23236377 | |
| 564 | Ubiquitination | EKEKELQKLTQEETN HHHHHHHHHHHHHHH | 67.15 | - | |
| 573 | 2-Hydroxyisobutyrylation | TQEETNFKSLVHDLF HHHHHHHHHHHHHHH | 44.97 | - | |
| 573 | Acetylation | TQEETNFKSLVHDLF HHHHHHHHHHHHHHH | 44.97 | 23954790 | |
| 573 | Ubiquitination | TQEETNFKSLVHDLF HHHHHHHHHHHHHHH | 44.97 | - | |
| 574 | Phosphorylation | QEETNFKSLVHDLFQ HHHHHHHHHHHHHHH | 31.33 | 21712546 | |
| 582 | Acetylation | LVHDLFQKVEEAKSS HHHHHHHHHHHHHHH | 44.26 | 25953088 | |
| 582 | Ubiquitination | LVHDLFQKVEEAKSS HHHHHHHHHHHHHHH | 44.26 | - | |
| 587 | 2-Hydroxyisobutyrylation | FQKVEEAKSSLAMNR HHHHHHHHHHHHCCC | 43.80 | - | |
| 587 | Ubiquitination | FQKVEEAKSSLAMNR HHHHHHHHHHHHCCC | 43.80 | - | |
| 588 | Phosphorylation | QKVEEAKSSLAMNRS HHHHHHHHHHHCCCC | 37.32 | 20044836 | |
| 589 | Phosphorylation | KVEEAKSSLAMNRSR HHHHHHHHHHCCCCH | 21.31 | 20044836 | |
| 595 | Phosphorylation | SSLAMNRSRGKVLDA HHHHCCCCHHHHHHH | 40.14 | 20044836 | |
| 598 | 2-Hydroxyisobutyrylation | AMNRSRGKVLDAIIQ HCCCCHHHHHHHHHH | 38.22 | - | |
| 598 | Acetylation | AMNRSRGKVLDAIIQ HCCCCHHHHHHHHHH | 38.22 | 30592473 | |
| 598 | Ubiquitination | AMNRSRGKVLDAIIQ HCCCCHHHHHHHHHH | 38.22 | - | |
| 607 | 2-Hydroxyisobutyrylation | LDAIIQEKKSGRIPG HHHHHHHHHCCCCCC | 35.54 | - | |
| 607 | Acetylation | LDAIIQEKKSGRIPG HHHHHHHHHCCCCCC | 35.54 | 23954790 | |
| 607 | Ubiquitination | LDAIIQEKKSGRIPG HHHHHHHHHCCCCCC | 35.54 | 21906983 | |
| 607 (in isoform 1) | Ubiquitination | - | 35.54 | 21890473 | |
| 607 (in isoform 2) | Ubiquitination | - | 35.54 | 21890473 | |
| 608 | Acetylation | DAIIQEKKSGRIPGI HHHHHHHHCCCCCCC | 58.34 | 30592485 | |
| 616 | Phosphorylation | SGRIPGIYGRLGDLG CCCCCCCCCCCCCCC | 11.34 | 20068231 | |
| 679 | 2-Hydroxyisobutyrylation | DKMAVWAKKMTEIQT HHHHHHHHHHCCCCC | 27.62 | - | |
| 679 | Acetylation | DKMAVWAKKMTEIQT HHHHHHHHHHCCCCC | 27.62 | 19608861 | |
| 680 | 2-Hydroxyisobutyrylation | KMAVWAKKMTEIQTP HHHHHHHHHCCCCCC | 43.22 | - | |
| 680 | Malonylation | KMAVWAKKMTEIQTP HHHHHHHHHCCCCCC | 43.22 | 26320211 | |
| 681 | Sulfoxidation | MAVWAKKMTEIQTPE HHHHHHHHCCCCCCC | 3.91 | 21406390 | |
| 682 | Phosphorylation | AVWAKKMTEIQTPEN HHHHHHHCCCCCCCC | 38.52 | 22817900 | |
| 686 | Phosphorylation | KKMTEIQTPENTPRL HHHCCCCCCCCCCCC | 37.93 | 22817900 | |
| 690 | Phosphorylation | EIQTPENTPRLFDLV CCCCCCCCCCCCHHE | 14.23 | 29083192 | |
| 698 | Ubiquitination | PRLFDLVKVKDEKIR CCCCHHEEECCHHHH | 51.36 | - | |
| 709 | Phosphorylation | EKIRQAFYFALRDTL HHHHHHHHHHHHHHH | 7.31 | 22817900 | |
| 739 | Phosphorylation | DRRWRVVTLQGQIIE CCCEEEEEEECEEEE | 15.54 | 24043423 | |
| 748 | Phosphorylation | QGQIIEQSGTMTGGG ECEEEEECCCCCCCC | 24.36 | 24043423 | |
| 750 | Phosphorylation | QIIEQSGTMTGGGSK EEEEECCCCCCCCCC | 19.46 | 24043423 | |
| 752 | Phosphorylation | IEQSGTMTGGGSKVM EEECCCCCCCCCCCC | 32.29 | 24043423 | |
| 756 | Phosphorylation | GTMTGGGSKVMKGRM CCCCCCCCCCCCCCC | 25.92 | 24043423 | |
| 760 | Ubiquitination | GGGSKVMKGRMGSSL CCCCCCCCCCCCCCE | 46.48 | - | |
| 765 | Phosphorylation | VMKGRMGSSLVIEIS CCCCCCCCCEEEEEC | 15.91 | 28450419 | |
| 766 | Phosphorylation | MKGRMGSSLVIEISE CCCCCCCCEEEEECH | 22.41 | 28450419 | |
| 787 | Phosphorylation | ESQLQNDSKKAMQIQ HHHHHHHHHHHHHHH | 43.54 | 28842319 | |
| 789 | Ubiquitination | QLQNDSKKAMQIQEQ HHHHHHHHHHHHHHH | 53.71 | - | |
| 797 | Ubiquitination | AMQIQEQKVQLEERV HHHHHHHHHHHHHHH | 31.06 | - | |
| 820 | Ubiquitination | EMRNTLEKFTASIQR HHHHHHHHHHHHHHH | 51.64 | - | |
| 822 | Phosphorylation | RNTLEKFTASIQRLI HHHHHHHHHHHHHHH | 30.48 | 23403867 | |
| 853 | 2-Hydroxyisobutyrylation | VLATAPDKKKQKLLE HHCCCCCHHHHHHHH | 61.89 | - | |
| 853 | Acetylation | VLATAPDKKKQKLLE HHCCCCCHHHHHHHH | 61.89 | 25953088 | |
| 853 | Ubiquitination | VLATAPDKKKQKLLE HHCCCCCHHHHHHHH | 61.89 | - | |
| 855 | Ubiquitination | ATAPDKKKQKLLEEN CCCCCHHHHHHHHHH | 59.41 | - | |
| 857 | Acetylation | APDKKKQKLLEENVS CCCHHHHHHHHHHHH | 65.01 | 25953088 | |
| 857 | Ubiquitination | APDKKKQKLLEENVS CCCHHHHHHHHHHHH | 65.01 | - | |
| 867 | Ubiquitination | EENVSAFKTEYDAVA HHHHHHHHHHHHHHH | 39.91 | - | |
| 876 | Acetylation | EYDAVAEKAGKVEAE HHHHHHHHHCCHHHH | 53.34 | 25953088 | |
| 876 | Ubiquitination | EYDAVAEKAGKVEAE HHHHHHHHHCCHHHH | 53.34 | - | |
| 885 | 2-Hydroxyisobutyrylation | GKVEAEVKRLHNTIV CCHHHHHHHHHHHHH | 40.52 | - | |
| 898 | Acetylation | IVEINNHKLKAQQDK HHHCCHHHHHHHHHH | 54.53 | 25953088 | |
| 898 | Ubiquitination | IVEINNHKLKAQQDK HHHCCHHHHHHHHHH | 54.53 | - | |
| 905 | Ubiquitination | KLKAQQDKLDKINKQ HHHHHHHHHHHHHHH | 55.00 | - | |
| 908 | Acetylation | AQQDKLDKINKQLDE HHHHHHHHHHHHHHH | 59.63 | 25953088 | |
| 922 | Ubiquitination | ECASAITKAQVAIKT HHHHHHHHHHHHHHH | 30.61 | - | |
| 928 | 2-Hydroxyisobutyrylation | TKAQVAIKTADRNLQ HHHHHHHHHHCHHHH | 28.11 | - | |
| 928 | Acetylation | TKAQVAIKTADRNLQ HHHHHHHHHHCHHHH | 28.11 | 25953088 | |
| 928 | Ubiquitination | TKAQVAIKTADRNLQ HHHHHHHHHHCHHHH | 28.11 | - | |
| 929 | Phosphorylation | KAQVAIKTADRNLQK HHHHHHHHHCHHHHH | 27.90 | 27174698 | |
| 936 | Ubiquitination | TADRNLQKAQDSVLR HHCHHHHHHHHHHHH | 51.70 | - | |
| 940 | Phosphorylation | NLQKAQDSVLRTEKE HHHHHHHHHHHHHHH | 15.80 | 30576142 | |
| 944 | Phosphorylation | AQDSVLRTEKEIKDT HHHHHHHHHHHHHHH | 47.45 | 30576142 | |
| 953 | Ubiquitination | KEIKDTEKEVDDLTA HHHHHHHHHHHHHHH | 66.19 | - | |
| 963 | Ubiquitination | DDLTAELKSLEDKAA HHHHHHHHHHHHHHH | 44.49 | - | |
| 968 | 2-Hydroxyisobutyrylation | ELKSLEDKAAEVVKN HHHHHHHHHHHHHHC | 39.87 | - | |
| 968 | Acetylation | ELKSLEDKAAEVVKN HHHHHHHHHHHHHHC | 39.87 | 25953088 | |
| 968 | Ubiquitination | ELKSLEDKAAEVVKN HHHHHHHHHHHHHHC | 39.87 | - | |
| 974 | Ubiquitination | DKAAEVVKNTNAAEE HHHHHHHHCCCHHHH | 64.33 | - | |
| 976 | Phosphorylation | AAEVVKNTNAAEESL HHHHHHCCCHHHHCH | 22.10 | 23312004 | |
| 982 | Phosphorylation | NTNAAEESLPEIQKE CCCHHHHCHHHHHHH | 40.50 | 25159151 | |
| 988 | Acetylation | ESLPEIQKEHRNLLQ HCHHHHHHHHHHHHH | 62.24 | 26051181 | |
| 988 | Ubiquitination | ESLPEIQKEHRNLLQ HCHHHHHHHHHHHHH | 62.24 | - | |
| 998 | Acetylation | RNLLQELKVIQENEH HHHHHHHHHHHHCHH | 36.22 | 25953088 | |
| 998 | Ubiquitination | RNLLQELKVIQENEH HHHHHHHHHHHHCHH | 36.22 | - | |
| 1009 | Acetylation | ENEHALQKDALSIKL HCHHHHHHHHHHHHH | 45.90 | 23954790 | |
| 1009 | Ubiquitination | ENEHALQKDALSIKL HCHHHHHHHHHHHHH | 45.90 | - | |
| 1013 | Phosphorylation | ALQKDALSIKLKLEQ HHHHHHHHHHHHHHH | 21.28 | - | |
| 1015 | Ubiquitination | QKDALSIKLKLEQID HHHHHHHHHHHHHHC | 35.87 | - | |
| 1030 | Phosphorylation | GHIAEHNSKIKYWHK CHHHHCCCCCCHHHH | 37.35 | 25159151 | |
| 1031 | Acetylation | HIAEHNSKIKYWHKE HHHHCCCCCCHHHHH | 48.84 | 25953088 | |
| 1031 | Ubiquitination | HIAEHNSKIKYWHKE HHHHCCCCCCHHHHH | 48.84 | - | |
| 1033 | Ubiquitination | AEHNSKIKYWHKEIS HHCCCCCCHHHHHHC | 46.13 | - | |
| 1037 | Acetylation | SKIKYWHKEISKISL CCCCHHHHHHCCCCC | 42.47 | 19608861 | |
| 1037 | Ubiquitination | SKIKYWHKEISKISL CCCCHHHHHHCCCCC | 42.47 | 19608861 | |
| 1041 | Ubiquitination | YWHKEISKISLHPIE HHHHHHCCCCCCCCC | 41.81 | - | |
| 1043 | Phosphorylation | HKEISKISLHPIEDN HHHHCCCCCCCCCCC | 25.10 | 24732914 | |
| 1054 (in isoform 2) | Ubiquitination | - | 41.08 | 21890473 | |
| 1056 | Phosphorylation | DNPIEEISVLSPEDL CCCCCEEEECCHHHH | 21.93 | 25159151 | |
| 1059 | Phosphorylation | IEEISVLSPEDLEAI CCEEEECCHHHHHHH | 24.88 | 25159151 | |
| 1067 | Ubiquitination | PEDLEAIKNPDSITN HHHHHHHCCCCHHHH | 70.27 | - | |
| 1071 | Phosphorylation | EAIKNPDSITNQIAL HHHCCCCHHHHHHHH | 32.35 | 24732914 | |
| 1073 | Phosphorylation | IKNPDSITNQIALLE HCCCCHHHHHHHHHH | 25.64 | 24732914 | |
| 1087 | Acetylation | EARCHEMKPNLGAIA HHHHHHCCCCHHHHH | 27.98 | 26051181 | |
| 1087 | Ubiquitination | EARCHEMKPNLGAIA HHHHHHCCCCHHHHH | 27.98 | - | |
| 1097 | Ubiquitination | LGAIAEYKKKEELYL HHHHHHHHCHHHHHH | 49.20 | - | |
| 1098 | Ubiquitination | GAIAEYKKKEELYLQ HHHHHHHCHHHHHHH | 65.60 | - | |
| 1099 | Ubiquitination | AIAEYKKKEELYLQR HHHHHHCHHHHHHHH | 52.87 | - | |
| 1112 | Ubiquitination | QRVAELDKITYERDS HHHHHHHHHHCCHHH | 49.96 | 21890473 | |
| 1112 (in isoform 1) | Ubiquitination | - | 49.96 | 21890473 | |
| 1115 | Phosphorylation | AELDKITYERDSFRQ HHHHHHHCCHHHHHH | 16.67 | - | |
| 1129 | Ubiquitination | QAYEDLRKQRLNEFM HHHHHHHHHHHHHHH | 47.25 | - | |
| 1129 (in isoform 2) | Ubiquitination | - | 47.25 | 21890473 | |
| 1145 | Ubiquitination | GFYIITNKLKENYQM HHHHHHHHHHHCCEE | 52.89 | - | |
| 1187 | Ubiquitination | PPKKSWKKIFNLSGG CCCCCHHHHHCCCCC | 46.39 | 21890473 | |
| 1187 (in isoform 1) | Ubiquitination | - | 46.39 | 21890473 | |
| 1192 | Phosphorylation | WKKIFNLSGGEKTLS HHHHHCCCCCCHHHH | 45.95 | 25367160 | |
| 1209 (in isoform 2) | Ubiquitination | - | 32.91 | 21890473 | |
| 1213 | Phosphorylation | ALHHYKPTPLYFMDE HHHHCCCCCEEEHHH | 23.05 | 28787133 | |
| 1215 (in isoform 2) | Ubiquitination | - | 5.91 | 21890473 | |
| 1222 (in isoform 2) | Ubiquitination | - | 24.60 | 21890473 | |
| 1227 (in isoform 2) | Ubiquitination | - | 6.88 | 21890473 | |
| 1266 | Phosphorylation | SDRLIGIYKTYNITK HHHHHEEEECCCCCC | 7.65 | - | |
| 1267 | Ubiquitination | DRLIGIYKTYNITKS HHHHEEEECCCCCCC | 42.48 | 21890473 | |
| 1267 (in isoform 1) | Ubiquitination | - | 42.48 | 21890473 | |
| 1273 | Ubiquitination | YKTYNITKSVAVNPK EECCCCCCCEECCHH | 38.85 | 21906983 | |
| 1273 (in isoform 1) | Ubiquitination | - | 38.85 | 21890473 | |
| 1280 | Ubiquitination | KSVAVNPKEIASKGL CCEECCHHHHHHCCC | 57.45 | 2190698 | |
| 1280 (in isoform 1) | Ubiquitination | - | 57.45 | 21890473 | |
| 1284 | Phosphorylation | VNPKEIASKGLC--- CCHHHHHHCCCC--- | 32.68 | 28122231 | |
| 1285 | Acetylation | NPKEIASKGLC---- CHHHHHHCCCC---- | 47.05 | 25953088 | |
| 1285 | Ubiquitination | NPKEIASKGLC---- CHHHHHHCCCC---- | 47.05 | - | |
| 1285 (in isoform 1) | Ubiquitination | - | 47.05 | 21890473 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SMC4_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SMC4_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SMC4_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| SMC2_HUMAN | SMC2 | physical | 9789013 | |
| CND2_HUMAN | NCAPH | physical | 17268547 | |
| CNDH2_HUMAN | NCAPH2 | physical | 17268547 | |
| AP3S1_HUMAN | AP3S1 | physical | 22863883 | |
| CCAR2_HUMAN | CCAR2 | physical | 22863883 | |
| CND2_HUMAN | NCAPH | physical | 22863883 | |
| RABL6_HUMAN | RABL6 | physical | 22863883 | |
| PLEC_HUMAN | PLEC | physical | 22863883 | |
| TBCD4_HUMAN | TBC1D4 | physical | 22863883 | |
| KIF2C_HUMAN | KIF2C | physical | 26344197 | |
| CND2_HUMAN | NCAPH | physical | 26344197 | |
| SMC1A_HUMAN | SMC1A | physical | 26344197 | |
| SMC2_HUMAN | SMC2 | physical | 26344197 | |
| HECD1_HUMAN | HECTD1 | physical | 26166704 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-381; LYS-679 AND LYS-1037,AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22; SER-28; THR-39;SER-41 AND SER-50, AND MASS SPECTROMETRY. | |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22 AND THR-39, AND MASSSPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-39; SER-41 AND SER-50,AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22 AND SER-27, AND MASSSPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-39 AND SER-982, AND MASSSPECTROMETRY. | |
| "Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-41 AND SER-1056, ANDMASS SPECTROMETRY. | |
| "Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22; SER-28 AND SER-41,AND MASS SPECTROMETRY. | |